Skip to main content

Advertisement

SpringerLink
Log in

The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

Aims

To identify cost-of-illness studies of Type 1 diabetes mellitus (Type 1 DM) in the United Kingdom (UK) and review this literature to estimate the current cost of Type 1 DM to the UK National Health Service.

Methods

Bibliographic databases and grey literature were searched systematically to identify all published and unpublished reporting of the costs of Type 1 DM in the UK. Studies were excluded if they did not present cost information from the UK or did not disaggregate information by diabetes type. Three grey literature sources and 11 published studies were identified for inclusion in the literature review.

Results

The included studies and reports covered topics including the overall cost of Type 1 DM, costs of individual diabetic complications and costs of specific interventions for Type 1 DM. The most recent published estimate of the cost of Type 1 DM was over 15 years old, and although this estimate has been inflated to current prices the estimate is not adjusted for changes to treatment pathways over this period and is therefore not considered an accurate estimate of current costs of Type 1 DM.

Conclusions

There is no recently published estimate of the cost of Type 1 DM in the UK; therefore, it is recommended that an up-to-date national, comprehensive cost-of-illness study should be conducted. Recommendations for the format of this study are made, including extending the scope to cover recent treatment developments and resource use where diabetes is a subsidiary diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Department of Health: Research funding and priorities. http://www.dh.gov.uk/en/Aboutus/Researchanddevelopment/AtoZ/DH_4069152 (2010). Accessed 10 April 2012

  2. BBC News: Diabetes and obesity rates on the rise, warns charity. http://www.bbc.co.uk/news/health-11605548 (2010). Accessed 10 April 2012

  3. Wilkinson, E.: Diabetes costs ‘out of control’. http://www.bbc.co.uk/news/health-10740224 (2010). Accessed 10 April 2012

  4. Ettaro, L., Songer, T., Zhang, P., Engelgau, M.: Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 22, 149–164 (2004)

    Article  PubMed  Google Scholar 

  5. Currie, C., Peters, J.: Trends in the volume and cost of prescribing for diabetes. Br. J. Med. Econ. 8, 1–9 (1995)

    Google Scholar 

  6. Donnan, P.T., Leese, G.P., Morris, A.D.: Hospitalizations for people With Type 1 and Type 2 diabetes compared with the nondiabetic population of Tayside, Scotland. Diabet. Care. 23, 1774–1779 (2000)

    Article  CAS  Google Scholar 

  7. Department of Health: Programme budgeting tools and data. http://www.dh.gov.uk/en/Managingyourorganisation/Financeandplanning/Programmebudgeting/DH_075743 (2012). Accessed 10 April 2012

  8. Gray, A., Fenn, P., McGuire, A.: The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales. Diabet. Med. 12, 1068–1076 (1995)

    Article  PubMed  CAS  Google Scholar 

  9. Drummond, M., Sculpher, M., Torrance, G., O’Brien, B., Stoddart, G.: Methods for the economic evaluation of health care programmes, 3rd edn. Oxford University Press, Oxford (2005)

    Google Scholar 

  10. Scottish Intercollegiate Guidelines Network: Search Filters: Economic Studies. http://www.sign.ac.uk/methodology/filters.html#econ (2011). Accessed 10 April 2012

  11. Department of Health: http://www.dh.gov.uk/en/index.htm (2012). Accessed 10 April 2012

  12. Yorkshire and Humber Public Health Observatory: http://www.yhpho.org.uk (2012). Accessed 10 April 2012

  13. Scottish Public Health Observatory: http://www.scotpho.org.uk (2012). Accessed 10 April 2012

  14. Public Health Wales: http://www.wales.nhs.uk/sitesplus/888/ (2012). Accessed 10 April 2012

  15. Ireland and Northern Ireland’s Population Health Observatory: http://www.inispho.org/ (2012). Accessed 10 April 2012

  16. The Information Centre: http://www.ic.nhs.uk (2012). Accessed 10 April 2012

  17. Diabetes UK: http://www.diabetes.org.uk (2012). Accessed 10 April 2012

  18. NHS Diabetes: http://www.diabetes.nhs.uk (2012). Accessed 10 April 2012

  19. National Institute for Health and Clinical Excellence: http://www.nice.org.uk (2012). Accessed 10 April 2012

  20. Diabetes.co.uk: http://www.diabetes.co.uk (2012). Accessed 10 April 2012

  21. Department of Health: Six years on: delivering the Diabetes National Service Framework. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_112509 (2010). Accessed 10 April 2012

  22. The Information Centre: National Diabetes Audit. http://www.ic.nhs.uk/diabetesaudits (2012). Accessed 10 April 2012

  23. The Information Centre: Health Survey for England. http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles-related-surveys/health-survey-for-england (2011). Accessed 10 April 2012

  24. Wanless, D.: Securing our future health: taking a long-term view. HM Treasury, London (2002)

    Google Scholar 

  25. Pagano, E., Brunetti, M., Tediosi, F., Garattini, L.: Costs of diabetes. A methodological analysis of the literature. Pharmacoeconomics 15, 583–595 (1999)

    Article  PubMed  CAS  Google Scholar 

  26. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: PRISMA 2009 Checklist. http://www.prisma-statement.org/statement.htm (2009). Accessed 13 July 2012

  27. Personal Social Services Research Unit: Unit Costs of Health and Social Care 2010. Compiled by Lesley Curtis, ed. University of Kent, Canterbury (2010)

  28. National Institute for Health and Clinical Excellence: Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus: review of technology appraisal guidance 57 (2008)

  29. Yorkshire and Humber Public Health Observatory: APHO Diabetes Prevalence Model. http://www.yhpho.org.uk/default.aspx?RID=81090 (2011). Accessed 10 April 2012

  30. Currie, C., Peters, J.: Costs of insulin-dependent diabetes mellitus. Diabet. Med. 13, 684–685 (1996)

    Article  PubMed  CAS  Google Scholar 

  31. Currie, C.J., Poole, C.D., Woehl, A., Morgan, C.L., Cawley, S., Rousculp, M.D., et al.: The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet. Med. 24, 187–194 (2007)

    Article  PubMed  CAS  Google Scholar 

  32. Hammer, M., Lammert, M., Mejias, S.M., Kern, W., Frier, B.M., Hammer, M., et al.: Costs of managing severe hypoglycaemia in three European countries. J. Med. Econ. 12, 281–290 (2009)

    Article  PubMed  Google Scholar 

  33. Leese, G.P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., et al.: Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26, 1176–1180 (2003)

    Article  PubMed  Google Scholar 

  34. Gordois, A., Scuffham, P., Shearer, A., Oglesby, A., Gordois, A., Scuffham, P., et al.: The health care costs of diabetic nephropathy in the United States and the United Kingdom. J. Diabet. Complicat. 18, 18–26 (2004)

    Article  Google Scholar 

  35. Evans, J.M., MacDonald, T.M., Leese, G.P., Ruta, D.A., Morris, A.D.: Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study. Diabetes Care 23, 770–774 (2000)

    Article  PubMed  CAS  Google Scholar 

  36. Poole, C., Tetlow, T., McEwan, P., Holmes, P., Currie, C.J.: The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis. Curr. Med. Res. Opin. 23, S41–S48 (2007)

    Article  Google Scholar 

  37. Colquitt, J.L., Green, C., Sidhu, M.K., Hartwell, D., Waugh, N.: Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol. Assess. 8, iii-171 (2004)

  38. Feltbower, R.G., Campbell, F.M., Bodansky, H.J., Stephenson, C.R., McKinney, P.A.: Insulin pump therapy in childhood diabetes-cost implications for Primary Care Trusts. Diabet. Med. 23, 86–89 (2006)

    Article  PubMed  CAS  Google Scholar 

  39. Office for National Statistics: Annual Mid-year Population Estimates, 2010. http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk–england-and-wales–scotland-and-northern-ireland/mid-2010-population-estimates/annual-mid-year-population-estimates–2010.pdf (2011). Accessed 13 July 2012

  40. de Lusignan, S., Khunti, K., Belsey, J., Hattersley, A., van Vlymen, J., Gallagher, H., et al.: A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. Diabet. Med. 27, 203–209 (2010)

    Article  PubMed  Google Scholar 

  41. Gray, J., Ekins, M., Scammell, A., Carroll, K., Majeed, A.: Workload implications of identifying patients with ischaemic heart disease in primary care: population-based study. J. Public Health Med. 25, 223–227 (2003)

    Article  PubMed  Google Scholar 

  42. de Lusignan, S., Gallagher, H., Chan, T., Thomas, N., Van Vlymen, J., Nation, M.: The QICKD study protocol: a cluster randomised trial to compare quality improvement interventions to lower systolic BP in chronic kidney disease (CKD) in primary care. Implement. Sci. 4, 39 (2009)

    Article  PubMed  Google Scholar 

  43. National Institute for Health and Clinical Excellence: Diabetes—insulin pump therapy: costing template. http://guidance.nice.org.uk/TA151/CostingTemplate/xls/English (2010). Accessed 10 Apr 2012

  44. Gerard, K., Donaldson, C., Maynard, A.: The cost of diabetes. Diabet. Med. 6, 164–170 (1989)

    Article  PubMed  CAS  Google Scholar 

  45. National Institute for Health and Clinical Excellence: Guidance on the use of patient-education models for diabetes (2003)

  46. Simell, T.T., Sintonen, H., Hahl, J., Simell, O.G.: Costs of insulin-dependent diabetes mellitus. Pharmacoeconomics 9, 24–38 (1996)

    Article  PubMed  CAS  Google Scholar 

  47. Rice, D.: Cost of illness studies: what is good about them? Inj. Prev. 6, 177–179 (2000)

    Article  PubMed  CAS  Google Scholar 

  48. The Information Centre: Healthcare Resource Groups 4 (HRG4). http://www.ic.nhs.uk/services/the-casemix-service/new-to-this-service/healthcare-resource-groups-4-hrg4 (2012). Accessed 10 April 2012

  49. Department of Health: NHS reference costs 2009–2010. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_123459 (2011). Accessed 10 April 2012

Download references

Acknowledgements

J.K. and A.B. received funds to conduct this research from the Juvenile Diabetes Research Foundation. We would like to acknowledge the help of Pippa Evans (School of Health and Related Research, University of Sheffield) in supporting the literature searches for this study.

Author information

Authors and Affiliations

  1. School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK

    Jen Kruger & Alan Brennan

Authors
  1. Jen Kruger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan Brennan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jen Kruger.

Appendix

Appendix

See Table 5.

Table 5 Studies excluded at the full text stage
Full size table

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kruger, J., Brennan, A. The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies. Eur J Health Econ 14, 887–899 (2013). https://doi.org/10.1007/s10198-012-0433-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-012-0433-4

Keywords

Search

Navigation